A Urokinase-type Plasminogen Activator-inhibiting Cyclic Peptide with an Unusual P2 Residue and an Extended Protease Binding Surface Demonstrates New Modalities for Enzyme Inhibition-Reference-Cited by-同舟云学术

A Urokinase-type Plasminogen Activator-inhibiting Cyclic Peptide with an Unusual P2 Residue and an Extended Protease Binding Surface Demonstrates New Modalities for Enzyme Inhibition

Published:2005-11 Issue:46 Volume:280 Page:38424-38437
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Hansen Martin,Wind Troels,Blouse Grant E.,Christensen Anni,Petersen Helle H.,Kjelgaard Signe,Mathiasen Lisa,Holtet Thor L.,Andreasen Peter A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference46 articles.

1. The crystal structure of the catalytic domain of human urokinase-type plasminogen activator

2. Introduction to Protein Structure;Brandén,1991

3. Serine Protease Mechanism and Specificity

4. Subtilisin. Stereochemical mechanism involving transition-state stabilization

5. Handbook of Proteolytic Enzymes;Barret,1998

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel genetically-encoded bicyclic peptide inhibitor of human urokinase-type plasminogen activator with better cross-reactivity toward the murine orthologue;Bioorganic & Medicinal Chemistry;2023-11

2. An Impedimetric Biosensing Strategy Based on BicyclicPeptides as Bioreceptors for Monitoring h-uPA Cancer Biomarkers;Chemosensors;2023-04-09

3. Nipple fluid for breast cancer diagnosis using the nanopore of Phi29 DNA-packaging motor;Nanomedicine: Nanotechnology, Biology and Medicine;2023-02

4. Urokinase plasminogen activator as an anti-metastasis target: inhibitor design principles, recent amiloride derivatives, and issues with human/mouse species selectivity;Biophysical Reviews;2022-01-06

5. Approaches for peptide and protein cyclisation;Organic & Biomolecular Chemistry;2021